| Sigma-2 Receptor |
MADURAMICIN |
Sigma2 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 2 |
PHENACEMIDE |
Adrenergic beta2 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
SAQUINAVIR |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
SAQUINAVIR |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
SAQUINAVIR |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
SAQUINAVIR |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
SAQUINAVIR |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
SERTRALINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
SERTRALINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| tachykinin receptor 1 |
NIMETAZEPAM |
Tachykinin NK1 |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
BOPINDOLOL |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
NORFLOXACIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
NORFLOXACIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
NORETHINDRONE ACETATE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
NORETHINDRONE ACETATE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
ACECLOFENAC |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
LANSOPRAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
ESTRIOL |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ESTRIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
HALOPERIDOL |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
HALOPERIDOL |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| natriuretic peptide receptor 2 |
ESTRIOL |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
| guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
ESTRIOL |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
| natriuretic peptide receptor 3 |
ESTRIOL |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
HALOPERIDOL |
GABAA, Agonist Site |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
MONOBENZONE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
MONOBENZONE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
MONOBENZONE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 3 |
SALBUTAMOL |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
PROCARBAZINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
PROCARBAZINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
CETYLPYRIDINIUM BROMIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
CETYLPYRIDINIUM BROMIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
PROBUCOL |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
RABEPRAZOLE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
RABEPRAZOLE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
RESVERATROL |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
RESVERATROL |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
RESVERATROL |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
CETYLPYRIDINIUM BROMIDE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
CETYLPYRIDINIUM BROMIDE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
RABEPRAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
RABEPRAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
CHLORAMBUCIL |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
CHLORAMBUCIL |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
GADOPENTETATE DIMEGLUMINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
GADOPENTETATE DIMEGLUMINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
GADOPENTETATE DIMEGLUMINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
GADOPENTETATE DIMEGLUMINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
GADOPENTETATE DIMEGLUMINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
GADOPENTETATE DIMEGLUMINE |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
CHLORDIAZEPOXIDE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
SIBUTRAMINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
SIBUTRAMINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
LACIDIPINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
PROPARACAINE |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
PROPARACAINE |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
SIBUTRAMINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
GADOPENTETATE DIMEGLUMINE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
GADOPENTETATE DIMEGLUMINE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
GADOPENTETATE DIMEGLUMINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
GADOPENTETATE DIMEGLUMINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 1 |
STANOZOLOL |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic, beta-1-, receptor |
STANOZOLOL |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| cysteinyl leukotriene receptor 1 |
PIRACETAM |
Leukotriene D4 |
-20% |
NoneNone |
NoneNone |
View
|
| cysteinyl leukotriene receptor 1 |
PIRACETAM |
Leukotriene D4 |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
NORFLOXACIN |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
SAQUINAVIR |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
SAQUINAVIR |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
RITONAVIR |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
DIGOXIN |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
RITONAVIR |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
RITONAVIR |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
RITONAVIR |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AZLOCILLIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| tachykinin receptor 1 |
KETAMINE |
Tachykinin NK1 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 beta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, delta |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type X, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage gated, type VIII, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
MEROPENEM |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 beta |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, delta |
CISPLATIN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
BROMOCRIPTINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
BROMOCRIPTINE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
VINORELBINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|